New oral cancer test uses saliva; iPad makes DEXIS 'immersive'

Dear DrBicuspid Member,

As more dentists screen for oral cancer as a routine part of patient exams, a variety of adjunctive technologies have entered the market, from fluorescence-based devices to brush biopsies.

Now a Pennsylvania start-up, PeriRx, is developing a unique molecular saliva test that analyzes certain biomarkers to specifically detect oropharyngeal squamous cell carcinoma and diabetes. The product is undergoing clinical trials and could be on the market in less than two years, according to the company. Read more in this latest Oral Cancer & Diagnostics Community feature.

Also coming soon is DEXIS go, a new app that integrates many features of the DEXIS Imaging Suite with the image display attributes of the iPad to create an immersive case presentation experience. Click here to read details based on an exclusive interview with one of the developers.

And in the ongoing discussion surrounding the ADA's plans to implement a series of cutbacks to the ADA Library services and staff, Dr. Spencer Bloom -- a private practice dentist in the Chicago area and a vocal supporter of the ADA Library -- questions the cost analysis the ADA is using to justify the cutbacks.

Page 1 of 114
Next Page